Literature DB >> 18771053

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Bruno Spire1, Patrizia Carrieri, Pal Sopha, Camelia Protopopescu, Narom Prak, Catherine Quillet, Chanchhaya Ngeth, Laurent Ferradini, Jean-François Delfraissy, Didier Laureillard.   

Abstract

BACKGROUND: The long-term maintenance of antiretroviral therapy (ART) remains an important issue, especially in limited-resource settings where additional barriers exist. A cross-sectional study was performed 24 months after ART initiation for patients treated in Cambodia in order to estimate the prevalence and identify determinants of non-adherence.
METHODS: Adults receiving ART for 24 +/- 2 months were considered eligible for the study. Self-reported non-adherence was defined according to an algorithm based on six items. The questionnaire also assessed ART-related side effects and HIV disclosure. HIV-1 RNA plasma viral load was measured using real-time PCR. Multivariate rare events logistic regression analysis was used to identify independent factors associated with non-adherence.
RESULTS: A total of 346 patients participated in the study. At 24 months, 95% of patients were adherent, 80% had HIV RNA <40 copies/ml and 75% had CD4+ T-cell counts >200 cells/mm3. Virological success was significantly higher in adherent patients than in non-adherent patients (81% versus 56%, P=0.021). Living in a rural area, limited HIV disclosure and perceived lipodystrophy were independently associated with non-adherence.
CONCLUSIONS: At 24 months, adherence to ART was high and explained positive virological outcomes. In order to maintain adherence and long-term virological benefits, special attention should be given to patients living in rural areas, those with lipodystrophy-related symptoms and others who express difficulties disclosing their condition to close family members.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771053

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  23 in total

Review 1.  Understanding HIV disclosure: a review and application of the Disclosure Processes Model.

Authors:  Stephenie R Chaudoir; Jeffrey D Fisher; Jane M Simoni
Journal:  Soc Sci Med       Date:  2011-04-06       Impact factor: 4.634

2.  Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Authors:  François-Xavier Blanc; Thim Sok; Didier Laureillard; Laurence Borand; Claire Rekacewicz; Eric Nerrienet; Yoann Madec; Olivier Marcy; Sarin Chan; Narom Prak; Chindamony Kim; Khemarin Kim Lak; Chanroeurn Hak; Bunnet Dim; Chhun Im Sin; Sath Sun; Bertrand Guillard; Borann Sar; Sirenda Vong; Marcelo Fernandez; Lawrence Fox; Jean-François Delfraissy; Anne E Goldfeld
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

3.  The Influence of PrEP-Related Stigma and Social Support on PrEP-Use Disclosure among Women Who Inject Drugs and Social Network Members.

Authors:  Marisa Felsher; Karley Dutra; Brent Monseur; Alexis M Roth; Carl Latkin; Oluwaseun Falade-Nwulia
Journal:  AIDS Behav       Date:  2021-05-20

4.  Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients.

Authors:  Monidarin Chou; Julie Bertrand; Olivier Segeral; Céline Verstuyft; Laurence Borand; Emmanuelle Comets; Clotilde Le Tiec; Laurent Becquemont; Vara Ouk; France Mentre; Anne-Marie Taburet
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

5.  Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).

Authors:  Sang Hoon Han; Jialun Zhou; Suneeta Saghayam; Sasheela Vanar; Nittaya Phanuphak; Yi-Ming A Chen; Thira Sirisanthana; Somnuek Sungkanuparph; Christopher K C Lee; Sanjay Pujari; Patrick C K Li; Shinichi Oka; Vonthanak Saphonn; Fujie Zhang; Tuti Parwati Merati; Matthew G Law; Jun Yong Choi
Journal:  Endocr J       Date:  2011-04-27       Impact factor: 2.349

6.  Factors associated with HIV status disclosure to one's steady sexual partner in PLHIV in Morocco.

Authors:  Mohamed Loukid; Alise Abadie; Emilie Henry; Mohamed Kamal Hilali; Lionel Fugon; Nadia Rafif; Othoman Mellouk; Ouarsas Lahoucine; Joanne Otis; Marie Préau
Journal:  J Community Health       Date:  2014-02

7.  The immunological response of HIV-positive patients initiating HAART at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Authors:  L Annison; A Dompreh; Y Adu-Sarkodie
Journal:  Ghana Med J       Date:  2013-12

8.  Contribution of HIV/AIDS-Related Human and Social Sciences Research to a Better Understanding of the Challenges of Hepatitis B Prevention, Diagnosis and Care.

Authors:  Charlotte Bauquier; Marie Préau
Journal:  Microorganisms       Date:  2021-05-28

9.  Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI).

Authors:  Hoa M Do; Michael P Dunne; Masaya Kato; Cuong V Pham; Kinh V Nguyen
Journal:  BMC Infect Dis       Date:  2013-03-27       Impact factor: 3.090

10.  Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study.

Authors:  Bach Xuan Tran; Long Thanh Nguyen; Nga Hoang Nguyen; Quynh Van Hoang; Jongnam Hwang
Journal:  Glob Health Action       Date:  2013-03-15       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.